Drug sales data analysis for outbreak detection of infectious diseases: A systematic literature review

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Pivette, Mathilde ^a,b,c   Mueller, Judith E ^a,d   Crépey, Pascal ^a,e   Bar Hen, Avner ^b  

^a EHESP SCHOOL OF PUBLIC HEALTH   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Celtipharm   (France)

^d INSTITUT PASTEUR   (France)

^e Aix Marseille University IRD 190 Inserm 1207   (France)

Author keywords

Communicable diseases; Disease outbreaks; Drug utilization; Epidemiology; Nonprescription drugs; Syndromic surveillance

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ALGORITHM; ARTICLE; DATA ANALYSIS; DISEASE SURVEILLANCE; DRUG MARKETING; EPIDEMIC; FLU LIKE SYNDROME; GASTROENTERITIS; GASTROINTESTINAL INFECTION; HUMAN; INCIDENCE; INFECTION; PERTUSSIS; PREDICTION; PUBLIC HEALTH PROBLEM; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; SYPHILIS; SYSTEMATIC REVIEW; COMMERCIAL PHENOMENA; COMMUNICABLE DISEASES; HEALTH SURVEY; INFORMATION PROCESSING; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

COMMERCE; COMMUNICABLE DISEASES; DATA COLLECTION; DISEASE OUTBREAKS; HUMANS; NONPRESCRIPTION DRUGS; POPULATION SURVEILLANCE; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES;

EID: 84964313940     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0604-2     Document Type: Article

References (42)

1. Henning KJ: What is syndromic surveillance? MMWR Morb Mortal Wkly Rep 2004, 53(Suppl):5-11.
2. CDC: Framework for evaluating public health surveillance systems for early detection of outbreaks: recommendations from the CEC working group. MMWR Morb Mortal Wkly Rep 2004, 53(RR-5):1-11.
3. Berger M, Shiau R, Weintraub JM: Review of syndromic surveillance: implications for waterborne disease detection. J Epidemiol Community Health 2006, 60:543-550.
4. Kara EO, Elliot AJ, Bagnall H, Foord DGF, Pnaiser R, Osman H, Smith GE, Olowokure B: Absenteeism in schools during the 2009 influenza A(H1N1) pandemic: a useful tool for early detection of influenza activity in the community? Epidemiol Infect 2011, 140:1-9.
5. Rolland E, Moore KM, Robinson VA, McGuinness D: Using Ontario's "Telehealth" health telephone helpline as an early-warning system: a study protocol. BMC Health Serv Res 2006, 6:10.
6. Rodman JS, Frost F, Jakubowski W: Using nurse hot line calls for disease surveillance. Emerg Infect Dis 1998, 4:329-332.
7. Lewis MD, Pavlin JA, Mansfield JL, O'Brien S, Boomsma LG, Elbert Y, Kelley PW: Disease outbreak detection system using syndromic data in the greater Washington DC area. Am J Prev Med 2002, 23:180-186.
8. Josseran L, Fouillet A, Caillère N, Brun-Ney D, Ilef D, Brucker G, Medeiros H, Astagneau P: Assessment of a syndromic surveillance system based on morbidity data: results from the Oscour network during a heat wave. PLoS One 2010, 5:e11984.
9. Mostashari F, Fine A, Das D, Adams J, Layton M: Use of ambulance dispatch data as an early warning system for communitywide influenzalike illness, New York City. J Urban Heal 2003, 80(2 Suppl 1):i43-i49.
10. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
11. Chen J-H, Schmit K, Chang H, Herlihy E, Miller J, Smith P: Use of Medicaid prescription data for syndromic surveillance-New York. MMWR Morb Mortal Wkly Rep 2005, 54(Suppl):31-34.
12. Chopra T, Binienda J, Mohammed M, Shyamraj R, Long P, Bach D, Carlton C, Peters S, Lephart P, Alangaden G, Dhar S, Marchaim D, Schreiber M, Kaye KS: A practical method for surveillance of novel H1N1 influenza using automated hospital data. Infect Control Hosp Epidemiol 2011, 32:700-702.
13. Couturier E, Michel A, Janier M, Dupin N, Semaille C: Syphilis surveillance in France, 2000-2003. Euro Surveill 2004, 9:8-10.
14. Das D, Metzger K, Heffernan R, Balter S, Weiss D, Mostashari F: Monitoring over-the-counter medication sales for early detection of disease outbreaks-New York City. MMWR Morb Mortal Wkly Rep 2005, 54(Suppl):41-46.
15. Davies GR, Finch RG: Sales of over-the-counter remedies as an early warning system for winter bed crises. Clin Microbiol Infect 2003, 9:858-863.
16. Edge VL, Pollari F, Lim G, Aramini J, Sockett P, Martin SW, Wilson J, Ellis A: Syndromic surveillance of gastrointestinal illness using pharmacy over-the-counter sales. a retrospective study of waterborne outbreaks in Saskatchewan and Ontario. Can J Public Heal 2004, 95:446-450.
17. Edge VL, Pollari F, Ng LK, Michel P, McEwen S a, Wilson JB, Jerrett M, Sockett PN, Martin SW: Syndromic surveillance of norovirus using over-the-counter sales of medications related to gastrointestinal illness. Can J Infect Dis Med Microbiol 2006, 17:235-241.
18. Hogan WR, Tsui F-C, Ivanov O, Gesteland P, Grannis S, Overhage JM: Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products. J Am Med Informatics Assoc 2003, 10:555-562.
19. Kirian ML, Weintraub JM: Prediction of gastrointestinal disease with over-the-counter diarrheal remedy sales records in the San Francisco Bay Area. BMC Med Inform Decis Mak 2010, 10:39.
20. Magruder SF: Evaluation of over-the-counter pharmaceutical sales as a possible early warning indicator of human disease. John Hopkins Univ Appl Phys Lab Tech Dig 2003, 24:349-353.
21. Magruder SF, Lewis SH, Najmi A, Florio E: Progress in understanding and using over-the-counter pharmaceuticals for syndromic surveillance. MMWR Morb Mortal Wkly Rep 2004, 53(Suppl):117-122.
22. Ohkusa Y, Shigematsu M, Taniguchi K, Okabe N: Experimental surveillance using data on sales of over-the-counter medications-Japan, November 2003-April 2004. MMWR Morb Mortal Wkly Rep 2005, 54 Suppl:47-52.
23. Polgreen PM, Yang M, Kuntz JL, Laxminarayan R, Cavanaugh JE: Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis. Infect Control Hosp Epidemiol 2011, 32:723-726.
24. Proctor ME, Blair KA, Davis JP: Surveillance data for waterborne illness detection: an assessment following a massive waterborne outbreak of Cryptosporidium infection. Epidemiol Infect 1998, 120:43-54.
25. Rodman JS, Frost F, Davis-Burchat L: Pharmaceutical sales; a method for disease surveillance? J Environ Health 1997, 60:8-14.
26. Stirling R, Aramini J, Ellis A, Lim G, Meyers R, Fleury M, Werker D: Waterborne cryptosporidiosis outbreak. Canada Commun Dis Rep 2001, 27:185-192.
27. Sugawara T, Ohkusa Y, Ibuka Y, Kawanohara H, Taniguchi K, Okabe N: Real-time prescription surveillance and its application to monitoring seasonal influenza activity in Japan. J Med Internet Res 2012, 14:e14.
28. Van den Wijngaard C, van Asten L, van Pelt W, Nagelkerke NJD, Verheij R, de Neeling AJ, Dekkers A, van der Sande MAB, van Vliet H, Koopmans MPG: Validation of syndromic surveillance for respiratory pathogen activity. Emerg Infect Dis 2008, 14:917-925.
29. Welliver RC, Cherry JD, Boyer KM, Deseda-Tous JE, Krause PJ, Dudley JP, Murray RA, Wingert W, Champion JG, Freeman G: Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res 1979, 13:1015-1017.
30. Yoshida M, Matsui T, Ohkusa Y, Kobayashi J, Ohyama T, Sugawara T, Yasui Y, Tachibana T, Okabe N: Seasonal influenza surveillance using prescription data for anti-influenza medications. Jpn J Infect Dis 2009, 62:233-235.
31. Cami A, Wallstrom GL, Fowlkes AL, Panozzo CA, Hogan WR: Mining aggregates of over-the-counter products for syndromic surveillance. Pattern Recognit Lett 2009, 30:255-266.
32. Li R, Wallstrom GL, Hogan WR: A multivariate procedure for identifying correlations between diagnoses and over-the-counter products from historical datasets. In AMIA Annu Symp Proc. 2005:450-454.
33. Pelat C, Boëlle P-Y, Turbelin C, Lambert B, Valleron A-J: A method for selecting and monitoring medication sales for surveillance of gastroenteritis. Pharmacoepidemiol Drug Saf 2010, 19:1009-1018.
34. Wallstrom GL, Hogan WR: Unsupervised clustering of over-the-counter healthcare products into product categories. J Biomed Inform 2007, 40:642-648.
35. Najmi A-H, Magruder SF: Estimation of hospital emergency room data using otc pharmaceutical sales and least mean square filters. BMC Med Inform Decis Mak 2004, 5:1-5.
36. Najmi A-H, Magruder SF: An adaptive prediction and detection algorithm for multistream syndromic surveillance. BMC Med Inform Decis Mak 2005, 5:33.
37. Vergu E, Grais RF, Sarter H, Fagot J-P, Lambert B, Valleron A-J, Flahault A: Medication sales and syndromic surveillance, France. Emerg Infect Dis 2006, 12:416-421.
38. Mandl KD, Overhage JM, Wagner MM, Lober WB, Sebastiani P, Mostashari F, Pavlin J, Gesteland P, Treadwell T, Koski E, Hutwagner L, Buckeridge DL, Aller RD, Grannis S: Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Informatics Assoc 2004, 11:141-150.
39. Meynard J-B, Chaudet H, Texier G, Ardillon V, Ravachol F, Deparis X, Jefferson H, Dussart P, Morvan J, Boutin J-P: Value of syndromic surveillance within the Armed Forces for early warning during a dengue fever outbreak in French Guiana in 2006. BMC Med Inform Decis Mak 2008, 8:29.
40. Miller J, Schmit K, Duncan P, Waters C: Increased antiviral medication sales before the 2005-06 influenza season-New York City. MMWR Morb Mortal Wkly Rep 2006, 55:277-279.
41. Frosst GO, Majowicz SE, Edge VL: Factors associated with the use of over-the-counter medications in cases of acute gastroenteritis in Hamilton, Ontario. Can J public Heal 2006, 97:489-493.
42. DMP-Dossier Médical Personnel. www.dmp.gouv.fr